The BRCA2-MEILB2-BRME1 complex governs meiotic recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells
Jingjing Zhang,Manickam Gurusaran,Yasuhiro Fujiwara,Kexin Zhang,Meriem Echbarthi,Egor Vorontsov,Rui Guo,Devon F. Pendlebury,Intekhab Alam,Gabriel Livera,Martini Emmanuelle,P. Jeremy Wang,Jayakrishnan Nandakumar,Owen R. Davies,Hiroki Shibuya
DOI: https://doi.org/10.1038/s41467-020-15954-x
IF: 16.6
2020-04-28
Nature Communications
Abstract:Abstract Breast cancer susceptibility gene II ( BRCA2 ) is central in homologous recombination (HR). In meiosis, BRCA2 binds to MEILB2 to localize to DNA double-strand breaks (DSBs). Here, we identify BRCA2 and MEILB2-associating protein 1 (BRME1), which functions as a stabilizer of MEILB2 by binding to an α-helical N-terminus of MEILB2 and preventing MEILB2 self-association. BRCA2 binds to the C-terminus of MEILB2, resulting in the formation of the BRCA2-MEILB2-BRME1 ternary complex. In Brme1 knockout ( Brme1 −/− ) mice, the BRCA2-MEILB2 complex is destabilized, leading to defects in DSB repair, homolog synapsis, and crossover formation. Persistent DSBs in Brme1 −/− reactivate the somatic-like DNA-damage response, which repairs DSBs but cannot complement the crossover formation defects. Further, MEILB2-BRME1 is activated in many human cancers, and somatically expressed MEILB2-BRME1 impairs mitotic HR. Thus, the meiotic BRCA2 complex is central in meiotic HR, and its misregulation is implicated in cancer development.
multidisciplinary sciences